SCHEMBL31747364

SCHEMBL31747364

C#CCCCOc1ccc(C(N)=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 12/20 0.60
▸ PARP15 Q460N3 5/20 0.49
▸ PARP2 Q9UGN5 3/20 0.49
▸ ALDH1A1 P00352 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ PARP14 Q460N5 1/20 0.48
▸ PARP16 Q8N5Y8 1/20 0.48
▸ PARP11 Q9NR21 1/20 0.48
▸ PARP4 Q9UKK3 1/20 0.48
▸ HRH3 Q9Y5N1 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ PRSS1 P07477 1/20 0.47
▸ TMPRSS2 O15393 1/20 0.47
▸ MAOB P27338 2/20 0.47
▸ TBXAS1 P24557 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31747443 0.92 PARP10 (0.62) PARP10PARP15PARP2ALDH1A1KMT2A
SCHEMBL24000908 0.85 PKM (0.61) ALDH1A1L3MBTL1
SCHEMBL21439587 0.83 PPARA (0.47) PARP10L3MBTL1PRSS1MAOB
SCHEMBL2705591 0.81 PRSS1 (0.53) PARP10PARP15PARP2KMT2APARP14
SCHEMBL20273256 0.81 PARP10 (0.59) PARP10PARP15PARP2ALDH1A1KMT2A
SCHEMBL9844963 0.80 MAOB (0.53) ALDH1A1L3MBTL1MAOBTBXAS1
SCHEMBL21439460 0.79 MAOB (0.44) L3MBTL1MAOB
SCHEMBL4687732 0.79 PARP10 (0.68) PARP10PARP15PARP2ALDH1A1KMT2A
SCHEMBL1109845 0.79 PARP10 (0.68) PARP10PARP15PARP2ALDH1A1KMT2A
Water SCHEMBL5055924 0.79 PARP10 (0.68) PARP10PARP15PARP2ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025262297-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 DARK BLUE THERAPEUTICS LTD (GB) 2025-12-26 — — WO disclosed
EP-4667467-A1 PROTAC DEGRADERS OF MLLT1 AND/OR MLLT3 Dark Blue Therapeutics Ltd (GB) 2025-12-24 — — EP disclosed
Send feedback